Unknown

Dataset Information

0

The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment.

ABSTRACT:

SUBMITTER: Toro C 

PROVIDER: S-EPMC8572160 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Thymic alterations in GM2 gangliosidoses model mice.
| S-EPMC2938369 | biostudies-literature
Transcriptomics Accumulated α-synuclein affects the progression of GM2 gangliosidoses
2015-05-12 | GSE68748 | GEO
Unknown GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies.
| S-EPMC7503724 | biostudies-literature
Unknown Combined replacement effects of human modified ?-hexosaminidase B and GM2 activator protein on GM2 gangliosidoses fibroblasts.
| S-EPMC5613250 | biostudies-literature
Unknown L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation.
| S-EPMC8619250 | biostudies-literature
Transcriptomics Accumulated α-synuclein affects the progression of GM2 gangliosidoses
2015-05-12 | E-GEOD-68748 | biostudies-arrayexpress
Unknown Natural history study of glycan accumulation in large animal models of GM2 gangliosidoses.
| S-EPMC7707493 | biostudies-literature
Unknown A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia.
| S-EPMC7821839 | biostudies-literature
Unknown Chitotriosidase as a biomarker for gangliosidoses.
| S-EPMC8498089 | biostudies-literature
Unknown Membrane lipids regulate ganglioside GM2 catabolism and GM2 activator protein activity.
| S-EPMC4548779 | biostudies-literature